S&P has also affirmed the “A-” rating on $796 million of Barnabas Health’s series 2006A, 2006B, 2011A, 2012A, 2014 and 2012 taxable bonds.
“The positive outlook reflects Barnabas Health’s operating strategies, which continue to result in growing earnings and cash flow,” said S&P credit analyst Cynthia Keller.
The rating affirmation is based on a number of factors, including Barnabas Health’s margin and cash flow growth and improved balance sheet ratios.
More articles on healthcare finance:
South Carolina hospital closing down Thursday
Physicians Realty Trust posts $152.8M in Q4 investments
Calif. rural hospital to cut labor and delivery services: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
